Cel-Sci Corporation (CVM) Social Stream
CEL SCI CORP (CVM) Price Targets From Analysts
Use the tables below to see what analysts covering CEL SCI CORP think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 24, 2022
The Trend in the Analyst Price Target
CVM's average price target has moved down $6 over the prior 45 weeks.
CVM reports an average of 430.21% for its upside potential over the past 45 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CVM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, CVM's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CVM as an investment opportunity.
- In terms of how CEL SCI CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than practically none of that group.
- In terms of how CEL SCI CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 51.88% of that group.
- In the context of Healthcare stocks, CEL SCI CORP's average analyst price target is higher than 103.07% of them.
- CVM has a greater upside potential (average analyst target price relative to current price) than 361.22% of stocks in the small market cap category.
What is the outlook for CVM? Use POWR Ratings for clearer insight into price direction.